Sedana Medical AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 34.26 million compared to SEK 26.54 million a year ago. Net loss was SEK 6.84 million compared to SEK 7.45 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.08 a year ago. Diluted loss per share from continuing operations was SEK 0.07 compared to SEK 0.08 a year ago.
For the nine months, sales was SEK 109.32 million compared to SEK 87.06 million a year ago. Net loss was SEK 21.54 million compared to SEK 37.57 million a year ago. Basic loss per share from continuing operations was SEK 0.22 compared to SEK 0.38 a year ago. Diluted loss per share from continuing operations was SEK 0.22 compared to SEK 0.38 a year ago.